PF-00489791 For The Treatment Of Raynaud's
Public ClinicalTrials.gov record NCT01090492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators propose that once daily administration of PF-00489791, a phosphodiesterase inhibitor, will reduce vasospasm and improve symptoms and signs associated with Primary and Secondary Raynaud's Phenomenon.
Study identification
- NCT ID
- NCT01090492
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 4, 2010 (Actual)
- Primary completion
- May 31, 2011 (Actual)
- Completion
- May 31, 2011 (Actual)
- Last update posted
- May 16, 2018
2010 – 2011
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Hospital and Outpatient Center | Redwood City | California | 94063 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030-5353 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Arthritis and Rheumatology of Georgia | Atlanta | Georgia | 30342 | — |
| Rockford Orthopedic Associates | Rockford | Illinois | 61107 | — |
| Diagnostic Rheumatology and Research, PC | Indianapolis | Indiana | 46227 | — |
| Memorial Health System, Inc. dba Memorial Medical Group Clinical Research Institute | South Bend | Indiana | 46601 | — |
| Johns Hopkins University - Division of Rheumatology | Baltimore | Maryland | 21224 | — |
| The Center for Rheumatology and Bone Research | Wheaton | Maryland | 20902 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01610 | — |
| University of Michigan | Ann Arbor | Michigan | 48106 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| West Michigan Rheumatology, PLLC | Grand Rapids | Michigan | 49546 | — |
| Physician Research Collaboration, LLC | Lincoln | Nebraska | 68516 | — |
| UMDNJ - Robert Wood Johnson Medical Center Clinical Research Center | New Brunswick | New Jersey | 08903-0019 | — |
| The Center for Rheumatology | Albany | New York | 12206 | — |
| Regional Rheumatology Associates | Binghamton | New York | 13905 | — |
| AAIR Research Center | Rochester | New York | 14618 | — |
| East Penn Rheumatology Associates, PC | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Rheumatic Disease Associates, Ltd. | Willow Grove | Pennsylvania | 19090 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01090492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01090492 live on ClinicalTrials.gov.